We are advancing three assets: (i) KETARx™ portfolio of ketamine drugs and data; (ii) PharmaPatch™ microneedle patch platform delivering ketamine, psychedelics, and GLP-1 drugs; and (iii) 49% ownership in Sairiyo Therapeutics Inc., developing a patented oral formulation of cepharanthine for infectious diseases and cancer.

Corporate Presentation

OTCQB: PHRRF | CSE: PHRM

Press Releases

Sign Up for Press Releases

Contact Us

PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario, M5C 1P1
​Canada
​Tel: 1-888-846-3171